$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

$lgnd Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000088616316000176 Filed on May 09, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$29.65M	$14.60M
YoY Change	103.04%	-8.5%
Cost Of Revenue	$955.0K	$1.074M
YoY Change	-11.08%	-56.18%
Gross Profit	$28.69M	$13.53M
YoY Change	112.1%	0.16%
Gross Profit Margin	96.78%	92.64%
Selling, General & Admin	$6.830M	$5.990M
YoY Change	14.02%	18.15%
% of Gross Profit	23.8%	44.28%
Research & Development	$4.004M	$3.368M
YoY Change	18.88%	7.57%
% of Gross Profit	13.95%	24.9%
Depreciation & Amortization	$2.575M	$650.0K
YoY Change	296.15%	-2.69%
% of Gross Profit	8.97%	4.8%
Operating Expenses	$4.004M	$3.368M
YoY Change	18.88%	7.57%
Operating Profit	$15.10M	$3.349M
YoY Change	350.76%	-34.33%
Interest Expense	$3.005M	$2.973M
YoY Change	1.08%	1098.79%
% of Operating Profit	19.91%	88.77%
Other Income/Expense, Net	-$5.525M	-$3.423M
YoY Change	61.41%	16.03%
Pretax Income	$9.571M	-$74.00K
YoY Change	-13033.78%	-103.44%
Income Tax	$3.694M	$15.00K
% Of Pretax Income	38.6%
Net Earnings	$6.608M	$754.0K
YoY Change	776.39%	-64.04%
Net Earnings / Revenue	22.29%	5.16%
Basic Earnings Per Share	$0.32	$0.04
Diluted Earnings Per Share	$0.30	$0.04
COMMON SHARES
Basic Shares Outstanding	20.71M shares	19.61M shares
Diluted Shares Outstanding	22.28M shares	20.63M shares

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$113.2M	$177.2M
YoY Change	-36.12%	600.4%
Cash & Equivalents	$31.29M	$165.8M
Short-Term Investments	$81.90M	$11.50M
Other Short-Term Assets	$1.562M	$926.0K
YoY Change	68.68%	10.11%
Inventory	$1.750M	$2.821M
Prepaid Expenses	$1.087M	$896.0K
Receivables	$11.80M	$7.400M
Other Receivables	$5.200M	$1.000M
Total Short-Term Assets	$133.1M	$191.7M
YoY Change	-30.59%	473.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$567.0K	$440.0K
YoY Change	28.86%	-36.23%
Goodwill	$73.00M	$12.24M
YoY Change	496.48%	0.0%
Intangibles	$212.8M	$50.13M
YoY Change	324.55%	-4.53%
Long-Term Investments	$28.12M
YoY Change
Other Assets	$70.00K	$358.0K
YoY Change	-80.45%	30.18%
Total Long-Term Assets	$480.4M	$71.51M
YoY Change	571.76%	-0.77%
TOTAL ASSETS
Total Short-Term Assets	$133.1M	$191.7M
Total Long-Term Assets	$480.4M	$71.51M
Total Assets	$613.4M	$263.2M
YoY Change	133.05%	149.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.688M	$7.442M
YoY Change	-63.88%	102.5%
Accrued Expenses	$3.669M	$4.263M
YoY Change	-13.93%	-21.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$600.0K	$2.300M
YoY Change	-73.91%	-72.94%
Total Short-Term Liabilities	$12.24M	$18.16M
YoY Change	-32.59%	-13.56%
LONG-TERM LIABILITIES
Long-Term Debt	$204.7M	$198.8M
YoY Change	2.97%	8543.48%
Other Long-Term Liabilities	$446.0K	$780.0K
YoY Change	-42.82%	11.59%
Total Long-Term Liabilities	$446.0K	$780.0K
YoY Change	-42.82%	11.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.24M	$18.16M
Total Long-Term Liabilities	$446.0K	$780.0K
Total Liabilities	$221.4M	$230.8M
YoY Change	-4.1%	470.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$395.4M	-$658.6M
YoY Change	-39.96%	-1.6%
Common Stock	$21.00K	$20.00K
YoY Change	5.0%	-4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$392.1M	$35.15M
YoY Change
Total Liabilities & Shareholders Equity	$613.4M	$263.2M
YoY Change	133.05%	149.57%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	$6.608M	$754.0K
YoY Change	776.39%	-64.04%
Depreciation, Depletion And Amortization	$2.575M	$650.0K
YoY Change	296.15%	-2.69%
Cash From Operating Activities	$13.11M	$7.579M
YoY Change	73.03%	194.1%
INVESTING ACTIVITIES
Capital Expenditures	$238.0K	$10.00K
YoY Change	2280.0%	66.67%
Acquisitions	$92.86M	$0.00
YoY Change
Other Investing Activities	-$79.50M	-$2.800M
YoY Change	2739.29%	180.0%
Cash From Investing Activities	-$79.76M	-$2.797M
YoY Change	2751.63%	180.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$502.0K	$0.00
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change		-100.0%
Cash From Financing Activities	$511.0K	$781.0K
YoY Change	-34.57%	-424.07%
NET CHANGE
Cash From Operating Activities	$13.11M	$7.579M
Cash From Investing Activities	-$79.76M	-$2.797M
Cash From Financing Activities	$511.0K	$781.0K
Net Change In Cash	-$66.14M	$5.563M
YoY Change	-1288.84%	315.77%
FREE CASH FLOW
Cash From Operating Activities	$13.11M	$7.579M
Capital Expenditures	$238.0K	$10.00K
Free Cash Flow	$12.88M	$7.569M
YoY Change	70.11%	194.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	LIGAND PHARMACEUTICALS INC
CY2015Q1	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	2402000	USD
CY2016Q1	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	600000	USD
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000886163
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20822444	shares
CY2014Q3	lgnd	Exercise Priceof Convertible Bond Hedge ExercisePriceofConvertibleBondHedge	75.05
CY2015Q1	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	586000	USD
CY2016Q1	lgnd	Collaborative Research And Development And Other Revenues CollaborativeResearchAndDevelopmentAndOtherRevenues	9917000	USD
CY2015Q4	lgnd	Commercial License Rights CommercialLicenseRights	8554000	USD
CY2016Q1	lgnd	Commercial License Rights CommercialLicenseRights	8546000	USD
CY2015Q4	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	10414000	USD
CY2016Q1	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	5285000	USD
CY2015Q4	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	268000	USD
CY2016Q1	lgnd	Deposits Liabilities Noncurrent DepositsLiabilitiesNoncurrent	298000	USD
CY2015Q1	lgnd	Effective Income Tax Rate Reconciliation Continuing Operations Percent EffectiveIncomeTaxRateReconciliationContinuingOperationsPercent	0.019
CY2016Q1	lgnd	Effective Income Tax Rate Reconciliation Continuing Operations Percent EffectiveIncomeTaxRateReconciliationContinuingOperationsPercent	0.394
CY2016Q1	lgnd	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Contingent Liabilities FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities	201000	USD
CY2016Q1	lgnd	Income Tax Provision Discontinued Operation Dilutedper Share IncomeTaxProvisionDiscontinuedOperationDilutedperShare	0.02
CY2015Q1	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	0.00
CY2016Q1	lgnd	Income Tax Provision Per Diluted Share IncomeTaxProvisionPerDilutedShare	0.17
CY2015Q1	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivable IncreaseDecreaseinFairValueofConvertibleDebtReceivable	0	USD
CY2016Q1	lgnd	Increase Decreasein Fair Valueof Convertible Debt Receivable IncreaseDecreaseinFairValueofConvertibleDebtReceivable	-15000	USD
CY2016Q1	lgnd	Lease Expiration Year Maximum LeaseExpirationYearMaximum	2023
CY2016Q1	lgnd	Lease Expiration Year Minimum LeaseExpirationYearMinimum	2016
CY2015Q4	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	3033000	USD
CY2016Q1	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	4022000	USD
CY2016Q1	lgnd	Maturity Period Of Highly Liquid Securities Maximum MaturityPeriodOfHighlyLiquidSecuritiesMaximum	P3M
CY2015Q1	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-3000	USD
CY2016Q1	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	-1306000	USD
CY2016Q1	lgnd	Non Restricted Equity And Debt Securities With Maturity Period NonRestrictedEquityAndDebtSecuritiesWithMaturityPeriod	P3M
CY2015Q1	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	200000	USD
CY2016Q1	lgnd	Operating Lease Adjustment For Accretion And Changes In Lease Assumptions OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions	200000	USD
CY2016Q1	lgnd	Operating Leases Future Minimum Payments Due After Four Years OperatingLeasesFutureMinimumPaymentsDueAfterFourYears	306000	USD
CY2016Q1	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due After Four Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueAfterFourYears	306000	USD
CY2016Q1	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due Next Twelve Months OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueNextTwelveMonths	1368000	USD
CY2016Q1	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Oneand Two Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinOneandTwoYears	847000	USD
CY2016Q1	lgnd	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Duein Threeand Four Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueinThreeandFourYears	348000	USD
CY2016Q1	lgnd	Operating Leases Future Minimum Payments Duein Oneand Two Years OperatingLeasesFutureMinimumPaymentsDueinOneandTwoYears	1767000	USD
CY2016Q1	lgnd	Operating Leases Future Minimum Payments Duein Threeand Four Years OperatingLeasesFutureMinimumPaymentsDueinThreeandFourYears	464000	USD
CY2016Q1	lgnd	Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Maximum OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMaximum	0.035
CY2016Q1	lgnd	Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Minimum OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMinimum	0.03
CY2015Q4	lgnd	Other Other Liabilities Noncurrent OtherOtherLiabilitiesNoncurrent	29000	USD
CY2016Q1	lgnd	Other Other Liabilities Noncurrent OtherOtherLiabilitiesNoncurrent	41000	USD
CY2015Q1	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	3247000	USD
CY2016Q1	lgnd	Payments To Contingent Value Right Holders PaymentsToContingentValueRightHolders	5446000	USD
CY2016Q1	lgnd	Sales Returns Restocking Fee Percent SalesReturnsRestockingFeePercent	0.2
CY2015Q1	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.085
CY2016Q1	lgnd	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate	0.050
CY2015Q4	lgnd	Short Term Portion Of Lease Exit Obligations ShortTermPortionOfLeaseExitObligations	934000	USD
CY2016Q1	lgnd	Short Term Portion Of Lease Exit Obligations ShortTermPortionOfLeaseExitObligations	577000	USD
CY2015Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	731000	USD
CY2016Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	475000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4083000	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2688000	USD
CY2015Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2016Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-320000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5397000	USD
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3669000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	726000	USD
CY2016Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	754000	USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	823000	USD
CY2016Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	937000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2781000	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2824000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4903000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3568000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	701478000	USD
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	783890000	USD
CY2014Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	11600000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	2914000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	4118000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2509000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2668000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2500000	USD
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3500000	shares
CY2015Q4	us-gaap	Assets Assets	530542000	USD
CY2016Q1	us-gaap	Assets Assets	613438000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	214712000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	133059000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	102791000	USD
CY2016Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	81908000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4944000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2988000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	44000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	97891000	USD
CY2016Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	78923000	USD
CY2015Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-3000	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	-1306000	USD
CY2015Q1	us-gaap	Business Exit Costs1 BusinessExitCosts1	223000	USD
CY2016Q1	us-gaap	Business Exit Costs1 BusinessExitCosts1	244000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160203000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	165766000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97428000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31293000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5563000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-66135000	USD
CY2014Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	125.08
CY2014Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3264643	shares
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	33333333	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19949012	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20815636	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19949012	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20815636	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	20000	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5134000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5274000	USD
CY2015Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	201985000	USD
CY2016Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	204653000	USD
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1074000	USD
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	955000	USD
CY2015Q1	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	594000	USD
CY2016Q1	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	2524000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2016Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	107000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	216564000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	157258000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	100000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	100000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	650000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2575000	USD
CY2015Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2016Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1139000	USD
CY2015Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	USD
CY2016Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	731000	USD
CY2016Q1	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	400000	USD
CY2015Q1	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	0	USD
CY2016Q1	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	408000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1711000	USD
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	854000	USD
CY2015Q4	us-gaap	Equity Method Investments EquityMethodInvestments	29728000	USD
CY2016Q1	us-gaap	Equity Method Investments EquityMethodInvestments	28118000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	10700000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10700000	USD
CY2016Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	15000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4782000	USD
CY2016Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4767000	USD
CY2016Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	2828000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9490000	USD
CY2016Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6863000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	10600000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10700000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	10700000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5994000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6825000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	12238000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	72997000	USD
CY2015Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-74000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9571000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-89000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	5877000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.28
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.26
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.04
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2015Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2016Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1605000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3694000	USD
CY2015Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	11000	USD
CY2016Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4667000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4302000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5211000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5604000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-6000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-4101000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-83000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	13000	USD
CY2015Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	14000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	150000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-853000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	291000	USD
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	749736	shares
CY2016Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	41000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-445000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16000	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	-661000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	0	USD
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	957369	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	759581	shares
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48347000	USD
CY2016Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	212823000	USD
CY2015Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	60585000	USD
CY2016Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	285820000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	2973000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	3005000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	903000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	919000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	915000	USD
CY2016Q1	us-gaap	Interest Payable Current InterestPayableCurrent	695000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	1633000	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	1750000	USD
CY2015Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2016Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2015Q4	us-gaap	Liabilities Liabilities	226151000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	221361000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	530542000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	613438000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20836000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12240000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	781000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	511000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2797000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79760000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7579000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13114000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	754000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	6608000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-843000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3423000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5525000	USD
CY2015Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4782000	USD
CY2016Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4767000	USD
CY2015Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11253000	USD
CY2016Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	14552000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3349000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15096000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4436000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1899000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	2869000	USD
CY2015Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	900000	USD
CY2016Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000	USD
CY2016Q1	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	8900000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1222000	USD
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	429000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1908000	USD
CY2016Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1562000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4614000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1098000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	234000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	236000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8000	USD
CY2016Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	21000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	297000	USD
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	446000	USD
CY2015Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1000	USD
CY2016Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-447000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	391000	USD
CY2015Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-1000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	0	USD
CY2015Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	502000	USD
CY2015Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	92855000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	238000	USD
CY2015Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2016Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	49892000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1177000	USD
CY2016Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1087000	USD
CY2015Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
CY2016Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	48401000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	459000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	20270000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	781000	USD
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1013000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-89000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	6608000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3153000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3391000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	372000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	567000	USD
CY2015Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-447000	USD
CY2016Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	406000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	6170000	USD
CY2016Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	11779000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3368000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4004000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-402010000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-395402000	USD
CY2015Q1	us-gaap	Revenues Revenues	14602000	USD
CY2016Q1	us-gaap	Revenues Revenues	29648000	USD
CY2015Q1	us-gaap	Royalty Revenue RoyaltyRevenue	10287000	USD
CY2016Q1	us-gaap	Royalty Revenue RoyaltyRevenue	14390000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3729000	USD
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5341000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2914000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4118000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.58
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	241015	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1683341	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1880327	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.23
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.50
CY2016Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	23.00
CY2016Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	88.84
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M22D
CY2016Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7M6D
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	102791000	USD
CY2016Q1	us-gaap	Short Term Investments ShortTermInvestments	81908000	USD
CY2016Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	44029	shares
CY2015Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2016Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	77615000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	304391000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	392077000	USD
CY2015Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	4614000	USD
CY2016Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1834000	USD
CY2016Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6100000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20630788	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22283979	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19611881	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20707926	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19612000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20708000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	61538	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	66736	shares
CY2016Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications<br clear="none"/> <br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to the previously issued balance sheet and statement of operations for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> for comparability purposes. These reclassifications had no effect on the reported net income, stockholders' equity, and operating cash flows as previously reported.<br clear="none"/></font></div><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000886163-16-000176-index-headers.html	Edgar Link	pending
0000886163-16-000176-index.html	Edgar Link	pending
0000886163-16-000176.txt	Edgar Link	pending
0000886163-16-000176-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lgnd-20160331.xml	Edgar Link	completed
lgnd-20160331.xsd	Edgar Link	pending
lgnd-20160331_cal.xml	Edgar Link	unprocessable
lgnd-20160331_def.xml	Edgar Link	unprocessable
lgnd-20160331_lab.xml	Edgar Link	unprocessable
lgnd-20160331_pre.xml	Edgar Link	unprocessable
lgnd-3311610q.htm	Edgar Link	pending
lgnd_33116exhibit311.htm	Edgar Link	pending
lgnd_33116exhibit312.htm	Edgar Link	pending
lgnd_33116exhibit321.htm	Edgar Link	pending
ligand-vikingxsecondamendm.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

2016 Q1 Form 10-Q Financial Statement

#000088616316000176 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND LIGAND PHARMACEUTICALS INC Stock $lgnd

2016 Q1 Form 10-Q Financial Statement

#000088616316000176 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd